NEW YORK — A new herb that could help treat heart disease and cancer has been discovered in the Philippines.
The botanical name for the herb is Woad, and it was developed by researchers at the University of the Philippines in Manila.
In the Philippines, Wood is a widely used herbal medicine that can be used to treat inflammation and pain.
This year, the drugmaker, Valeant Pharmaceuticals Inc., released the first batch of Wox, which is manufactured by the company.
It is made by Cayman Pharmaceuticals Ltd., a unit of Valeant.
The drugmaker is developing the drug for treatment of chronic heart disease, and cancer.
About 15 million people in the country use Wox.
Wax is the resin used to make the drug.
When used to relieve pain and inflammation, Wox can be taken orally, injected or taken as a tablet.
Valeant has said it will sell the drug through a retail distribution channel.
We’ll be able to get it through our retail channels, said Mark Bensinger, Valeent’s president and chief executive officer.
Bensinger said Valeant would sell the Wools in the United States.
The Drug Enforcement Administration (DEA) and other U.S. drug regulators have banned the sale of the drug in the U.K., Germany, France, Belgium and Spain.
There is no approval for Wox in the Netherlands.
Last month, Valeance announced it was buying generic drugmaker AstraZeneca Plc for $3.3 billion.